GLUE insider files option exercise and planned sales

Insider transaction filing for GLUE.

Rhea-AI Filing Summary

Insider transaction filing for GLUE. A filer reported the exercise of 6,000 stock options and concurrent sale activity under an established trading arrangement. The record shows 10b5-1 sales of 30,000 shares on 06/24/2026 for $642,681 and 11,845 shares on 06/23/2026 for $239,522.50. The transactions are reported for sale on NASDAQ.

Insights

Securities Compliance Analyst

Routine disclosure of option exercise and planned 10b5-1 sales.

The filing documents an exercise of 6,000 stock options and two 10b5-1 sales totaling 41,845 shares across 06/23–06/24/2026. These details indicate routine liquidity management rather than an unscheduled open‑market disposition.

Timing, plan terms, and any post‑transaction holdings are not provided in the excerpt; subsequent filings may disclose remaining holdings or plan specifics.

Key Figures

Option exercise: 6,000 shares 10b5-1 sale (06/24/2026): 30,000 shares 10b5-1 sale (06/23/2026): 11,845 shares +1 more

4 metrics

Option exercise 6,000 shares exercise of stock options

10b5-1 sale (06/24/2026) 30,000 shares proceeds $642,681

10b5-1 sale (06/23/2026) 11,845 shares proceeds $239,522.50

Aggregate shares sold (excerpt) 41,845 shares sum of reported 10b5-1 transactions in excerpt

Key Terms

10b5-1, Form 144, exercise of stock options

3 terms

10b5-1 regulatory

"10b5-1 Sales for FILIP JANKU 321 Harrison Avenue, Suite 900"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | Issuer Information | Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of stock options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer | 6000"

FAQ

What did GLUE report in the Form 144 filing?

The filing reports an exercise of 6,000 stock options and 10b5-1 sales of 30,000 shares on 06/24/2026 and 11,845 shares on 06/23/2026, with proceeds listed for each sale.

How much did the 10b5-1 sales raise according to the filing?

The filing shows proceeds of $642,681 from the 06/24/2026 sale of 30,000 shares and $239,522.50 from the 06/23/2026 sale of 11,845 shares.

Who is identified as the seller in the Form 144 for GLUE?

The excerpt names sales executed under a 10b5-1 arrangement for Filip Janku at the address shown; the filing lists Morgan Stanley Smith Barney LLC as broker on the cover line.

Were the shares sold on an exchange or privately?

The filing lists NASDAQ as the market identifier for the securities and records transactions with cash consideration, indicating exchange‑market sales rather than noncash transfers.

Does the filing state remaining holdings after these transactions?

The provided excerpt does not state resulting holdings or total shares owned after the transactions; additional disclosures would be required to show post‑transaction positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001862930
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MONTE ROSA THERAPEUTICS INC
SEC File Number	001-40522
Address of Issuer	321 Harrison Avenue, Suite 900 Boston MASSACHUSETTS 02118
Phone	617-949-2643
Name of Person for Whose Account the Securities are To Be Sold	FILIP JANKU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	133740.00	84479418	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/29/2026	Exercise of Stock Options	Issuer			6000	06/29/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for FILIP JANKU 321 Harrison Avenue, Suite 900 Boston MA 02118	Common	06/24/2026	30000	642681.00
10b5-1 Sales for FILIP JANKU 321 Harrison Avenue, Suite 900 Boston MA 02118	Common	06/23/2026	11845	239522.50

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Filip Janku
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)